OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Drug–Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study
Alessandra Mangia, Francesco Scaglione, Pierluigi Toniutto, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 13, pp. 7144-7144
Open Access | Times Cited: 14
Alessandra Mangia, Francesco Scaglione, Pierluigi Toniutto, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 13, pp. 7144-7144
Open Access | Times Cited: 14
Showing 14 citing articles:
A Real-World Analysis of the Population with Hepatitis C Virus Infection Affected by Type 2 Diabetes in Italy: Patients’ Characteristics, Comorbidity Profiles and Treatment Patterns
Edoardo G. Giannini, Alessandra Mangia, Filomena Morisco, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 614-614
Open Access
Edoardo G. Giannini, Alessandra Mangia, Filomena Morisco, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 614-614
Open Access
Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administrative claims database in Japan
Daisuke Nakamoto, Yi Piao, Hajime Mizutani, et al.
Journal of Pharmaceutical Health Care and Sciences (2025) Vol. 11, Iss. 1
Open Access
Daisuke Nakamoto, Yi Piao, Hajime Mizutani, et al.
Journal of Pharmaceutical Health Care and Sciences (2025) Vol. 11, Iss. 1
Open Access
Comorbidities and Contraindicated Medications in Patients with Chronic Hepatitis C Infection in Japan: a Real-World Database Study
Takeya Tsutsumi, Hiroshi Yotsuyanagi
Kanzo (2024) Vol. 65, Iss. 8, pp. 368-390
Open Access | Times Cited: 2
Takeya Tsutsumi, Hiroshi Yotsuyanagi
Kanzo (2024) Vol. 65, Iss. 8, pp. 368-390
Open Access | Times Cited: 2
Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study
Vicki Wing‐Ki Hui, Christopher Langjun Au, Amy Lam, et al.
Hepatology International (2022) Vol. 16, Iss. 6, pp. 1318-1329
Closed Access | Times Cited: 11
Vicki Wing‐Ki Hui, Christopher Langjun Au, Amy Lam, et al.
Hepatology International (2022) Vol. 16, Iss. 6, pp. 1318-1329
Closed Access | Times Cited: 11
Sofosbuvir–velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan
Tetsuo Takehara, Namiki Izumi, Satoshi Mochida, et al.
Hepatology Research (2022) Vol. 52, Iss. 10, pp. 833-840
Open Access | Times Cited: 9
Tetsuo Takehara, Namiki Izumi, Satoshi Mochida, et al.
Hepatology Research (2022) Vol. 52, Iss. 10, pp. 833-840
Open Access | Times Cited: 9
Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study
Jeong Heo, Yoon Jun Kim, Sung Wook Lee, et al.
The Korean Journal of Internal Medicine (2023) Vol. 38, Iss. 4, pp. 504-513
Open Access | Times Cited: 5
Jeong Heo, Yoon Jun Kim, Sung Wook Lee, et al.
The Korean Journal of Internal Medicine (2023) Vol. 38, Iss. 4, pp. 504-513
Open Access | Times Cited: 5
Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life
Nicola Pugliese, Davide Polverini, Ivan Arcari, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 11, pp. 502-502
Open Access | Times Cited: 5
Nicola Pugliese, Davide Polverini, Ivan Arcari, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 11, pp. 502-502
Open Access | Times Cited: 5
Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
S. Fagiuoli, Pierluigi Toniutto, Nicola Coppola, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 57-65
Open Access | Times Cited: 4
S. Fagiuoli, Pierluigi Toniutto, Nicola Coppola, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 57-65
Open Access | Times Cited: 4
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders
Heiner Wedemeyer, V. Di Marco, Montserrat García‐Retortillo, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2493-2493
Open Access | Times Cited: 7
Heiner Wedemeyer, V. Di Marco, Montserrat García‐Retortillo, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2493-2493
Open Access | Times Cited: 7
Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence
Yolanda Prado, Diego Aravena, Felipe M. Llancalahuén, et al.
Advances in experimental medicine and biology (2023), pp. 25-47
Closed Access | Times Cited: 2
Yolanda Prado, Diego Aravena, Felipe M. Llancalahuén, et al.
Advances in experimental medicine and biology (2023), pp. 25-47
Closed Access | Times Cited: 2
Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis
Felice Nava, Alessandra Mangia, Marco Riglietta, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 645-656
Open Access | Times Cited: 2
Felice Nava, Alessandra Mangia, Marco Riglietta, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 645-656
Open Access | Times Cited: 2
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project
Claudio Borghi, Alessia Ciancio, Ivan Gentile, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6946-6946
Open Access | Times Cited: 3
Claudio Borghi, Alessia Ciancio, Ivan Gentile, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6946-6946
Open Access | Times Cited: 3
Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project
Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, et al.
Italian Journal of Medicine (2024) Vol. 18, Iss. 4
Open Access
Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, et al.
Italian Journal of Medicine (2024) Vol. 18, Iss. 4
Open Access
Comorbidities and the use of comedications among patients with chronic hepatitis C in Korea: A nationwide cross-sectional study
Kyung Min Kwon, Jae‐Jun Shim, Gi‐Ae Kim, et al.
The Korean Journal of Internal Medicine (2023) Vol. 38, Iss. 3, pp. 338-348
Open Access | Times Cited: 1
Kyung Min Kwon, Jae‐Jun Shim, Gi‐Ae Kim, et al.
The Korean Journal of Internal Medicine (2023) Vol. 38, Iss. 3, pp. 338-348
Open Access | Times Cited: 1
